---
title: "ETHK Labs Sets March 2026 Board Meeting to Approve 2025 Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278742026.md"
description: "ETHK Labs Inc. has scheduled a board meeting for March 27, 2026, to review and approve its audited annual results for the financial year ending December 31, 2025. The board will also consider declaring a final dividend and address other corporate matters. The announcement confirms the current board composition, which includes three executive directors, two non-executive directors, and three independent non-executive directors. The latest analyst rating for IVD Medical Holding Limited (HK:1931) is a Hold with a price target of HK$1.50."
datetime: "2026-03-11T14:38:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278742026.md)
  - [en](https://longbridge.com/en/news/278742026.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278742026.md)
---

# ETHK Labs Sets March 2026 Board Meeting to Approve 2025 Results

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

IVD Medical Holding Limited ( (HK:1931) ) has issued an update.

ETHK Labs Inc. has scheduled a board meeting for 27 March 2026 to review and approve the group’s audited annual results for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, if any, and address other corporate matters, signaling an upcoming disclosure of financial performance and potential shareholder returns for the year.

The announcement also restates the current composition of the board, listing three executive directors, two non-executive directors and three independent non-executive directors. This confirms the company’s governance lineup as it approaches a key financial reporting date, providing investors with clarity on oversight ahead of the release of the 2025 annual results.

The most recent analyst rating on (HK:1931) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.

**More about IVD Medical Holding Limited**

ETHK Labs Inc., formerly known as IVD Medical Holding Limited, is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. The group operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a standard governance structure for a Hong Kong-listed corporate issuer.

**Average Trading Volume:** 4,698,216

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$1.95B

### Related Stocks

- [01931.HK](https://longbridge.com/en/quote/01931.HK.md)

## Related News & Research

- [ETHK Labs Rebrands with New English Name and Stock Short Name in Hong Kong](https://longbridge.com/en/news/273715634.md)
- [21:00 ETExecutives' Club Announces Programs for 2026-2027 Season](https://longbridge.com/en/news/286834335.md)
- [Decisive Dividend Corporation Announces June 2026 Dividend](https://longbridge.com/en/news/286559251.md)
- [Nordic wins 2026 Swaay.Health award for health IT blog of the year](https://longbridge.com/en/news/286260284.md)
- [ING Groep Reports Progress on €1 Billion Share Buyback Programme](https://longbridge.com/en/news/286895445.md)